Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to $99.5 million.

  • Neurogene's Change in Acquisitions & Divestments rose 103714.29% to $99.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.0 million, marking a year-over-year increase of 26039.53%. This contributed to the annual value of $74.0 million for FY2024, which is 138000.0% up from last year.
  • Neurogene's Change in Acquisitions & Divestments amounted to $99.5 million in Q3 2025, which was up 103714.29% from $68.0 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Change in Acquisitions & Divestments ranged from a high of $99.5 million in Q3 2025 and a low of $5.0 million during Q4 2023
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $24.8 million (2024), whereas its average is $36.4 million.
  • The largest annual percentage gain for Neurogene's Change in Acquisitions & Divestments in the last 5 years was 103714.29% (2025), contrasted with its biggest fall of 4900.0% (2025).
  • Over the past 3 years, Neurogene's Change in Acquisitions & Divestments (Quarter) stood at $5.0 million in 2023, then skyrocketed by 215.0% to $15.8 million in 2024, then skyrocketed by 531.75% to $99.5 million in 2025.
  • Its last three reported values are $99.5 million in Q3 2025, $68.0 million for Q2 2025, and $44.7 million during Q1 2025.